| Product |
CAS |
Molecular formula |
More |
| Pritumumab |
499212-74-7 |
C6440H9968N1708O2016S42 |
More |
| Acid brown85 (c.i. 34900) |
77031-30-2 |
|
More |
| Almitrine-raubasine |
76997-30-3 |
C26H29F2N7.C21H24N2O3 |
More |
| Piperazine-1-carboxamidine hemisulfate |
22365-47-5 |
C5H14N4O4S |
More |
| (3Ar)-7α-bromo-1,3,3aβ,4aα,5,6,7,8,8aβ,9-decahydro-4a,8,8-trimethy |
77249-86-6 |
C15H23BrO2 |
More |
| O,o-di(4-bromophenyl)thiophosphoryl chloride |
77628-32-1 |
C12H8Br2ClO2PS |
More |
| L-threo-pentonic acid, 2-deoxy-, .gamma.-lactone |
78185-09-8 |
C5H8O4 |
More |
| Glyceryl behenate |
77538-19-3 |
C25H50O4 |
More |
| 3-Butyl-1,1,2-trimethyl-1h-benzo[e]indolium hexafluorophosphate(v) |
545387-09-5 |
C19H24N.F6P |
More |
| Raxibacumab |
565451-13-0 |
|
More |
| Glyphosphate-trimesium |
81591-81-3 |
C6H16NO5PS |
More |
| Dicyclohexylamine 3-oxo-1-phenyl-2,7,10-trioxa-4-azadodecan-12-oate |
560088-84-8 |
C26H42N2O6 |
More |
| 6-(2-Propenyl)-ergoline-8-carboxylic acid |
81409-74-7 |
C18H20N2O2 |
More |
| Tasidotin hydrochloride |
623174-20-9 |
C32H58N6O5.ClH |
More |
| 5-Chloro-n-(2-chloro-4-nitrophenyl)salicylamide, compound with piperaz |
81424-66-0 |
2(C13H8Cl2N2O4).C4H10N2 |
More |
| Bis[[4-[[4-(diethylamino)phenyl][4-(ethylamino)-1-naphthyl]methylene]c |
82338-76-9 |
2(C33H40N3).Fe(CN)6.2Cu |
More |
| Catridecacog |
606138-08-3 |
|
More |
| (±)-n-(2-hydroxyethyl)-2-[4-(2-methylpropyl)phenyl]propionamide |
82821-47-4 |
C15H23NO2 |
More |
| 2,5,8,11,14,17,20,23,26,29-Decaoxahentriacontane-31-thiol |
651042-85-2 |
C21H44O10S |
More |
| Diniconazole (+)-form |
83657-19-6 |
C15H17Cl2N3O |
More |
|
